Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis

Pediatric Pulmonology

Volumn 45, Issue 11, 2010, Pages 1145-1148

  Hayes Jr , Don ^a   Murphy, Brian S ^a   Lynch, James E ^a   Feola, David J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

aerosolized; allergic bronchopulmonary aspergillosis; amphotericin B; Aspergillus fumigatus; cystic fibrosis; inhaled

Indexed keywords

AMPHOTERICIN B; CEFEPIME; ITRACONAZOLE; METHYLPREDNISOLONE; PREDNISONE; TOBRAMYCIN;

ADOLESCENT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLOSIS; CASE REPORT; CONTINUOUS INFUSION; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITALIZATION; HUMAN; LUNG TRANSPLANTATION; OXYGEN THERAPY; PRIORITY JOURNAL; PSEUDOMONAS INFECTION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; BRONCHIECTASIS; CYSTIC FIBROSIS; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; ITRACONAZOLE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 78449291939     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21300     Document Type: Article

References (26)

1. Laufer P, Fink JN, Bruns WT, Unger GF, Kalbfleisch JH, Greenberger PA, Patterson R,. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984; 73: 44 - 48.
2. Simmonds EJ, Littlewood JM, Evans EG,. Cystic fibrosis and allergic bronchopulmonary aspergillosis. Arch Dis Child 1990; 65: 507 - 511.
3. Knutsen AP, Hutcheson PS, Mueller KR, Slavin RG,. Serum immunoglobulins E and G anti-Aspergillus fumigatus antibody in patients with cystic fibrosis who have allergic bronchopulmonary aspergillosis. J Lab Clin Med 1990; 116: 724 - 727.
4. Nepomuceno IB, Esrig S, Moss RB,. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 1999; 115: 364 - 370.
5. Geller DE, Kaplowitz H, Light MJ, Colin AA,. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Chest 1999; 116: 639 - 646.
6. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, Skov M, Maish W, Mastella G, Participants in the Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37: S225 - S264.
7. Becker JW, Burke W, McDonald G, Greenberger PA, Henderson WR, Aitken ML,. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest 1996; 109: 1536 - 1540.
8. Beaumont F, Kauffman HF, de Monchy JG, Sluiter HJ, de Vries K,. Volumetric aerobiological survey of conidial fungi in the North-East Netherlands. II. Comparison of aerobiological data and skin tests with mould extracts in an asthmatic population. Allergy 1985; 40: 181 - 186.
9. Kauffman HF, Tomee JF, van der Werf TS, de Monchy JG, Koeter GK,. Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 1995; 151: 2109 - 2115, discussion 2116.
10. Greenberger PA,. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110: 685 - 692.
11. Kauffman HF, Beaumont F, Sluiter HJ, de Vries K,. Immunologic observations in sera of a patient with allergic bronchopulmonary aspergillosis by means of the enzyme-linked immunosorbent assay. J Allergy Clin Immunol 1984; 74: 741 - 746.
12. Chetty A,. Pathology of allergic bronchopulmonary aspergillosis. Front Biosci 2003; 8: e110 - e114.
13. Levy MB,. Allergic bronchopulmonary aspergillosis and cystic fibrosis. Front Biosci 2003; 8: s579 - s583.
14. Rapaka RR, Kolls JK,. Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med Mycol 2009; 47: S331 - S337.
15. Kuiper L, Ruijgrok EJ,. A review on the clinical use of inhaled amphotericin B. J Aerosol Med Pulm Drug Deliv 2009; 22: 213 - 227.
16. Breslin AB, Jenkins CR,. Experience with allergic bronchopulmonary aspergillosis: some unusual features. Clin Allergy 1984; 14: 21 - 28.
17. Greenberger PA, Patterson R,. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 1988; 81: 646 - 650.
18. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, Bamberger DM, Weinmann AJ, Tuazon CU, Judson MA, Platts-Mills TA, DeGraff AC, Jr., A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756 - 762.
19. Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, Simpson JL, McElduff P, Gibson PG,. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111: 952 - 957.
20. Wark PA, Gibson PG, Wilson AJ,. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 2004; (3): CD001108.
21. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF,. Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327 - 360.
22. Casey P, Garrett J, Eaton T,. Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin. J Heart Lung Transplant 2002; 21: 1237 - 1241.
23. Laoudi Y, Paolini JB, Grimfed A, Just J,. Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA? Eur Respir J 2008; 31: 908 - 909.
24. van der Ent CK, Hoekstra H, Rijkers GT,. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 2007; 62: 276 - 277.
25. Zirbes JM, Milla CE,. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 2008; 43: 607 - 610.
26. Kanu A, Patel K,. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol 2008; 43: 1249 - 1251.